Chordia Therapeutics Reports July Exercise Status of Ninth Tranche Warrant

TOKYO, Aug 03 (Pulse News Wire) – Chordia Therapeutics Inc. (190A.T) reported the exercise status of its ninth tranche warrant for the month of July.

As of August 03, 2026, the company had issued the warrants with an adjustment clause for exercise price. In July, none of the warrants were exercised, resulting in zero shares being delivered. The total number of outstanding warrants remained unchanged at 25,664 out of 25,664. The company noted that during the observation period, there were no instances of warrant exercises.

At the end of June, the number of unexercised warrants stood at 25,664. By the end of July, this figure was still 25,664. Additionally, the total number of issued shares at the end of June was 77,258,400, excluding treasury shares. Regarding compliance with exercise restrictions based on the Tokyo Stock Exchange's Listing Regulations Article 434 and the Securities Association’s Rules on Handling Third-Party Allotment Equity Issues, the company stated that the combined delivery share count remains at 0, with the ratio of exercise limitations standing at 0.00%.

For more detailed information on the issuance of the ninth tranche warrant with an exercise price adjustment clause, refer to the press release dated September 5, 2025, titled “Announcement Regarding the Issuance of the Ninth Tranche Warrant with Exercise Price Adjustment Clause and the Third-Party Allocation Issue of the Tenth and Eleventh Tranches.”.